Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 50
Report ID | 109116 |
Drug Identification Number | 02341689 |
Brand name | GD-DICLOFENAC/MISOPROSTOL 50 |
Common or Proper name | GD-DICLO/MISO 50 |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MISOPROSTOL DICLOFENAC SODIUM |
Strength(s) | 200MCG 50MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 250's |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-19 |
Estimated end date | 2020-12-30 |
Actual end date | 2020-04-23 |
Shortage status | Resolved |
Updated date | 2020-04-24 |
Company comments | Current available inventory and scheduled deliveries will be preventatively managed through local allocation until approximately end of December 2020. Other presentation available: Arthrotec 50mg |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-04-24 | English | Compare |
v4 | 2020-04-23 | French | Compare |
v3 | 2020-04-23 | English | Compare |
v2 | 2020-03-20 | French | Compare |
v1 | 2020-03-20 | English | Compare |
Showing 1 to 5 of 5